Literature DB >> 25484545

Pseudohyperphosphatemia due to contamination with heparin: A case for caution.

S Senthilkumaran1, R G Menezes2, S Jayaraman3, P Thirumalaikolundusubramanian4.   

Abstract

Entities:  

Year:  2014        PMID: 25484545      PMCID: PMC4244731          DOI: 10.4103/0971-4065.133040

Source DB:  PubMed          Journal:  Indian J Nephrol        ISSN: 0971-4065


× No keyword cloud information.
Sir, With reference to an informative letter by Amalnath and Dubashi,[1] we would like to share our experience of preanalytical error resulting in pseudohyperphosphatemia due to contamination of blood sample with heparin obtained from on central venous catheter. A 26-year-old software engineer was brought to the emergency department after an episode of syncopal attack. He recovered spontaneously, but was dyspneic and diaphoretic. There were no evidences of seizure activity or incontinence. He denied history of chest pain, palpitation, cough, bleeding manifestations, aura, herbal supplements, illicit drugs, or any regular medication. On examination, he was found to have tachycardia, tachypnea, hypotension, and hypoxia in room air. His blood chemistry revealed normal serum electrolytes, glucose, blood urea, and creatinine. His coagulation profile and complete blood count were unremarkable. His computed tomography (CT) of the brain was negative for bleeding, aneurysm or an embolic event. Further evaluation revealed deep vein thrombosis involving the origin of the right common iliac vein down to the level of the distal right femoral vein and proximal long saphenous vein. CT pulmonary angiogram showed bilateral pulmonary emboli in the segmental branches and he was given standard anticoagulation treatment with unfractionated heparin. We were puzzled with his very high and fluctuating levels of phosphorus levels, even though he did not receive any phosphate containing drugs nor alterations in his dietary pattern. There was no evidence of bleeding, hemolysis or rhabdomyolysis. His liver function, lipid profile, plasma lactate, and parathyroid hormone levels were normal. Analytical error was suspected, as the clinical and other laboratory values could not explain hyperphosphatemia. On further interrogation, we noticed his blood samples were drawn from the central line, the patency of which was maintained by heparinized saline. Repeat blood specimens drawn simultaneously from other peripheral vein revealed normal serum phosphorus level (4.6 mg/dl). Unexplained hyperphosphatemia in chronic kidney disease patients are often blamed to nonadherence of dietary restrictions or phosphate binders. However, if it is noticed in a patient with a central line, the differential diagnosis of hyperphosphatemia shall include the use of heparin[2] or tissue plasminogen activator,[3] which may erroneously increase serum phosphate levels due to improper sampling. According to the manufacturer's package insert, heparinized saline is buffered with phosphate solution, which contains approximately 105 mg/dl of phosphate. Based on our case coupled with previous reports,[24] we attribute the source for elevated phosphate concentration to blood samples contaminated with heparinized solution. Ball et al.[4] have concluded that even minute amount of heparin contamination contributes to significant elevation of serum phosphate levels. Schiller et al.[5] suggested adherence to strict blood drawing procedures from indwelling catheters so as to avoid contaminated samples resulting in factitious laboratory values/reports. The concept of pseudohyperphosphatemia secondary to heparin flush contributing to preanalytical error does not receive due attention. Therefore, it is worth considering spurious hyperphosphatemia in the differential diagnosis of unexplained elevated phosphorus level with normal serum calcium.
  4 in total

1.  Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter.

Authors:  Cindy L Ball; Kathleen Tobler; B Catherine Ross; M Ruth Connors; Martha E Lyon
Journal:  Clin Chem Lab Med       Date:  2004-01       Impact factor: 3.694

2.  Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter.

Authors:  Francois Cachat; Daniel Bardy; Claudine Durussel; Ermindo Di Paolo
Journal:  Pediatr Nephrol       Date:  2005-12-03       Impact factor: 3.714

3.  Spurious hyperphosphatemia in patients on hemodialysis with catheters.

Authors:  Brigitte Schiller; Bhupinder Virk; Martin Blair; Amy Wong; John Moran
Journal:  Am J Kidney Dis       Date:  2008-06-05       Impact factor: 8.860

4.  Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia.

Authors:  S D Amalnath; B Dubashi
Journal:  Indian J Nephrol       Date:  2013-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.